Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolerability and Efficacy of Cannabidiol on Motor Symptoms in Parkinson's Disease
NCT03582137Phase 2Completed
- Sponsor
- University of Colorado Denver
- Start
- Sep 2018
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cannabidiol in Parkinson's disease (PD), sponsored by University of Colorado Denver. Started Sep 2018; status: completed.
02
Drugs
cannabidiol
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT03582137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03582137.